Medical Device
Manufacturing
THE TRADE PAPER OF THE FACTORY FLOOR
Z-1689-2025Class II

IceSeed 1.5 CX NEEDLE OUS, Cryoablation Needle, REF H7493967534170. The needles are intended to convert...

Boston Scientific Corporation / initiated 2025-03-24 / Open, Classified / root cause: manufacturing process

Boston Scientific Corporation began a recall of IceSeed 1.5 CX NEEDLE OUS, Cryoablation Needle, REF H7493967534170. The needles are intended to convert high-pressure gas to either a very cold Freezing... on . FDA classified it as Class II and gives the reason as "Boston Scientific has identified that IceSeedTM CX needles manufactured between April 2024 and February 2025 have been programmed with DEMO settings instead of Commercial settings (see Affected Product Listing). Upon...". As of , the recall status on record is Open, Classified, and MDM tags the root cause as manufacturing process.

Recall record

Recall number
Z-1689-2025
Classification
Class II
Status
Open, Classified
Initiated
Posted
Recalling firm
Boston Scientific Corporation
Product
IceSeed 1.5 CX NEEDLE OUS, Cryoablation Needle, REF H7493967534170. The needles are intended to convert high-pressure gas to either a very cold Freezing application or to a warm Thawing application.
Product code
GEH Unit, Cryosurgical, Accessories
Reason for recall
Boston Scientific has identified that IceSeedTM CX needles manufactured between April 2024 and February 2025 have been programmed with DEMO settings instead of Commercial settings (see Affected Product Listing). Upon initial connection of an IceSeed CX needle to the Cryoablation System, the user will be prompted to perform the Needle Integrity and Functionality Test (NIT) per standard protocols. The affected needles perform as intended unless they are disconnected and reconnected to any channel after testing. In this case, the Cryoablation System will prompt re-execution of the NIT.
Root cause tag
manufacturing process
FDA root cause
Process control
Action
Boston Scientific issued a Product Advisory notice to its consignees on 03/24/2025 via Fed Ex, email, and hand delivery. The notice explained the issue, clinical impact, and provided the following recommendations: " Avoid disconnecting and reconnecting these IceSeed CX Cryoablation Needles from/to the Cryoablation System. " Maintain initial connection of IceSeed CX Cryoablation Needles to the Cryoablation System and the IceSeed CX Cryoablation Needles will perform as intended. The consignee was also directed to immediately post this information in a visible location near the affected products to ensure it is readily accessible to all handlers and users of the device. Share this notice with any health care professional within your organization and with any entities where the affected devices may have been transferred and complete the acknowledgement form and return it to [email protected] (email) or Fax to: Field Action Center 1-763-415-7708.
Quantity in commerce
67 units
Distribution
Nationwide
Product codes and lots
GTIN00191506032708, Batch Numbers: 33988638, 33988639, 34309895, 34309896, 34392269, 34392270, 34392271, 34564920.

Enforcement reports

One row per recalled product line
FDA enforcement reports joined to recall event Z-1689-2025
Recall numberClassStatusVoluntary or mandatedReport dateClassified
Z-1686-2025Class IIOngoingVoluntary: Firm initiated
Z-1687-2025Class IIOngoingVoluntary: Firm initiated
Z-1688-2025Class IIOngoingVoluntary: Firm initiated
Z-1689-2025Class IIOngoingVoluntary: Firm initiated